Anatomical and Functional Assessment of Coronary Artery Disease Using Whole-Heart Dynamic Computed Tomography
Anatomical and Functional Assessment of Coronary Artery Disease Using Whole-Heart Dynamic Computed Tomography
批准号:
9918155
负责人:
Logan Charles Hubbard
金额:
$5.05万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-01 至 2021-06-11
关键词:
AnatomyAngiographyAnteriorAnterior Descending Coronary ArteryClinicalCoronary ArteriosclerosisDataDiagnosticDiffuseDiseaseDoseElectrocardiogramFamily suidaeFutureHealthHeartHyperemiaImageInjectionsInterobserver VariabilityLeftLesionLesion by MorphologyMeasurementMeasuresMedicalMicrospheresMicrovascular DysfunctionModalityMorbidity - disease rateMorphologic artifactsMyocardial IschemiaMyocardial perfusionPatient riskPatientsPercutaneous Transluminal Coronary AngioplastyPerfusionPhysiciansProtocols documentationRadiation Dose UnitReference StandardsResearchRiskScanningScientistSeveritiesStenosisTechniquesTimeTrainingVisualX-Ray Computed Tomographybasecalcificationconnective tissue-activating peptideimprovedlow dose computed tomographymortalitynovelprospective
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Coronary artery disease (CAD) is the leading cause of morbidity and mortality worldwide. Fortunately,
morbidity and mortality are significantly reduced when patients are risk stratified using computed
tomography angiography (CTA) and treated appropriately with medical therapy or revascularization.
Unfortunately, CTA is limited in that lesion severity is based solely on lesion morphology; hence,
collateralization, calcification, and artifacts often confound diagnostic results. Visual grading of CAD
also has high intra- and inter-observer variability, and often correlates poorly with myocardial ischemia,
especially for intermediate severity focal disease (30-70% luminal narrowing), diffuse disease, and
microvascular disease. Hence, CTA alone cannot fully characterize the true severity of CAD, and
functional assessment techniques, such as dynamic computed tomography perfusion (CTP), are
necessary, in conjunction with CTA, for more objective indication of CAD significance. Unfortunately,
such dynamic CTP techniques systematically underestimate perfusion and deliver unacceptably high
radiation doses per CAD exam, hampering their widespread clinical utility.
Given the limitations of CTA and dynamic CTP, this proposal aims to validate an accurate, low-dose,
CTA and dynamic CTP fusion technique based on first-pass analysis (FPA CTAP) for combined
anatomical and functional assessment of CAD. The central hypothesis is that simultaneous acquisition
of CTA and dynamic CTP data using a whole-heart CT scanner, two volume scans, and a single
contrast injection will enable accurate, low-dose, vessel-specific myocardial perfusion measurement.
Specifically, I aim to determine if vessel-specific myocardial perfusion can be accurately measured in
15 swine through retrospective implementation of the FPA CTAP technique. I also aim to determine if
vessel-specific myocardial perfusion can be accurately measured in 15 more swine through low-dose
prospective implementation of the FPA CTAP technique.
By validating such a combined approach to CAD assessment, this research may ultimately reduce the
contrast and radiation dose associated with CTA and dynamic CTP, while improving measurement
accuracy, making anatomical and functional assessment of CAD more accessible and impactful to
patients in need.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金